A Novel TRPC6 Mutation Causes Autosomal Dominant FSGS
Rohan Bhattacharya, Xingrui Mou, Sophia M. Leeman, Alekshyander Mishra, Titilola D. Kalejaiye, Megan Stangl, Daniel Silas, Karen L. Soldano, Christopher John Sperati, Opeyemi A. Olabisi, Gentzon Hall, Samira Musah
The paper reports a novel TRPC6 mutation causing autosomal dominant FSGS and shows that combined Sildenafil and Losartan therapy improves podocyte dysfunction.
bioRxiv · Feb 11, 2025 · PreprintGenetics